Michael Scolaro

Michael Scolaro

Oct 20, 2017

Group 6 Copy 109
0
    Please wait...

    About This Project

    We have invented a Nanocarrier that targets the Immune System to deliver Curcumin, an anti-inflammatory agent, to the brain for the treatment of neurodegenerative diseases, such as Chronic Traumatic Encephalopathy.

    Our preclinical study at Charles River Labs and the U. of Arizona, is being conducted to establish proof of effective nanocarrier delivery of Curcumin to the cells of the brain damaged by repeated traumatic athletic injuries to the head.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Managing Congenital Adrenal Hyperplasia in the Amish Population

    Congenital adrenal hyperplasia (CAH) is a disorder that affects the production of hormones critical for...

    Can we Measure the Body's Response to Implants by Testing the Blood?

    Would you or a loved one someday benefit from a life-saving medical implant? However, the organisms adapt...

    A Leap Forward to Cure a Neglected Disease

    The World Health Organization estimates that as many as 11 million people worldwide are infected with the...

    Backer Badge Funded